Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 17'th Jun 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth
08:21am, Saturday, 15'th Jun 2024
Globus Medical faced market backlash post-merger with NuVasive, but Q1 FY 2024 showed strong growth and integration efforts. Management revised net sales guidance for FY 2024, aiming for high growth a
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term
10:45am, Friday, 14'th Jun 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Globus Medical (GMED) Up 7.4% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 06'th Jun 2024
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
10:56am, Friday, 31'st May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why You Should Retain Globus Medical (GMED) Stock Now
10:31am, Friday, 31'st May 2024
Investors are optimistic about Globus Medical (GMED) led by strong musculoskeletal prospects and raised guidance.
Globus Medical (GMED) Hits 52-Week High: What's Driving It?
09:56am, Thursday, 23'rd May 2024
Globus Medical (GMED) outperforms the industry due to its stellar quarterly performance and impactful launches.
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
10:56am, Wednesday, 15'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GMED or PEN: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 09'th May 2024
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportuni
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
10:16am, Thursday, 09'th May 2024
Globus Medical (GMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
10:46am, Wednesday, 08'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
09:56am, Wednesday, 08'th May 2024
Globus Medical (GMED) delivers massive sales and earnings growth in the first quarter of 2024.
Globus Medical, Inc. (GMED) Q1 2024 Earnings Call Transcript
11:24pm, Tuesday, 07'th May 2024
Globus Medical, Inc. (NYSE:GMED ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development and Investor Relations Daniel
Globus Medical (GMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
07:01pm, Tuesday, 07'th May 2024
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street e
Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
06:31pm, Tuesday, 07'th May 2024
Globus Medical (GMED) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.53 per share a year ago.
